Green tea consumption and cognitive function: A cross-sectional study from the Tsurugaya Project

American Journal of Clinical Nutrition

Volumn 83, Issue 2, 2006, Pages 355-361

  Kuriyama, Shinichi ^a   Hozawa, Atsushi ^a   Ohmori, Kaori ^a   Shimazu, Taichi ^a   Matsui, Toshifumi ^a   Ebihara, Satoru ^a   Awata, Shuichi ^a   Nagatomi, Ryoichi ^a   Arai, Hiroyuki ^a   Tsuji, Ichiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cognitive function; Elderly; Green tea; Japanese; Mini mental state examination

Indexed keywords

GREEN TEA EXTRACT;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GERIATRIC CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUTRITIONAL ASSESSMENT; PREVALENCE; PROPHYLAXIS; QUESTIONNAIRE; TEA; AGING; BEVERAGE; CHEMISTRY; COFFEE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; GERIATRIC ASSESSMENT; JAPAN; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RISK;

ANIMALIA;

AGED; AGING; BEVERAGES; CAMELLIA SINENSIS; COFFEE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; FEMALE; GERIATRIC ASSESSMENT; HUMANS; JAPAN; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PSYCHOMETRICS; QUESTIONNAIRES; TEA;

EID: 33644858479     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.2.355     Document Type: Article

References (35)

1. Ritchie K, Lovestone S. The dementias. Lancet 2002;360:1759-66.
2. Essink-Bot ML, Pereira J, Packer C, Schwarzinger M, Burstrom K. Cross-national comparability of burden of disease estimates: the Eur Disability Weights Project. Bull World Health Organ 2002;80:644-52.
3. Nourhashemi F, Gillette-Guyonnet S, Andrieu S, et al. Alzheimer disease: protective factors. Am J Clin Nutr 2000;71(suppl):S643-9.
4. Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol 2004;3:579-87.
5. Cummings JL. Alzheimer's disease. N Engl J Med 2004;351:56-67.
6. Haan MN, Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 2004;25:1-24.
7. Mandel S, Youdim MB. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 2004;37:304-17.
8. Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 2003;17:952-4.
9. Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002;277:30574-80.
10. Reznichenko L, Amit T, Youdim MB, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 2005;93:1157-67.
11. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-6.
12. Selkoe DJ. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994;10:373-403.
13. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001;78:1073-82.
14. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-8.
15. Linn RT, Wolf PA, Bachman DL, et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995;52:485-90.
16. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839-44.
17. Hozawa A, Ebihara S, Ohmori K, et al. Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya Project. Hypertens Res 2004;27:557-61.
18. Ohmori K, Ebihara S, Kuriyama S, et al. The relationship between body mass index and a plasma lipid peroxidation biomarker in an older, healthy Asian community. Ann Epidemiol 2005;15:80-4.
19. Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL. Effectiveness of a geriatric evaluation unit. A randomized clinical trial. N Engl J Med 1984;311:1664-70.
20. Stuck AE, Aronow HU, Steiner A, et al. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med 1995;333:1184-9.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
22. Launer LJ. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology 1992;11(suppl 1):S2-13.
23. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med 1991;115:122-32.
24. Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M, Rose TL. Screening tests for geriatric depression. Clin Gerontol 1982;1:37-44.
25. Stewart AL, Hays RD, Ware JE. The MOS Short-form General Health Survey. Reliability and validity in a patient population. Med Care 1988;26:724-35.
26. SAS Institute Inc. SAS/STAT User's Guide, release 9.1 edition. Cary, NC: SAS Institute Inc, 2004.
27. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004;3:343-53.
28. Khokhar S, Magnusdottir SG. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 2002;50:565-70.
29. Nakagawa K, Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol (Tokyo) 1997;43:679-84.
30. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998;19:1771-6.
31. Abd El Mohsen MM, Kuhnle G, Rechner AR, et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 2002;33:1693-702.
32. Letenneur L. Risk of dementia and alcohol and wine consumption: a review of recent results. Biol Res 2004;37:189-93.
33. Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia. J Am Geriatr Soc 2004;52:540-6.
34. Science and Technology Agency of Japan: Standard Tables of Food Composition in Japan. 5th revised ed. Tokyo, Japan: Printing Bureau, Ministry of Finance, 2001 (in Japanese).
35. Ogawa K, Tsubono Y, Nishino Y, et al. Dietary sources of nutrient consumption in a rural Japanese population. J Epidemiol 2002;12:1-8.